Is a complete SILO research report available?

No complete published report is available for Silo Pharma, Inc. (SILO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Silo Pharma, Inc. (SILO)

NASDAQ: SILO · USD

$1.30

+0.01 (+0.8%)· Recorded snapshot

Market cap	2.1M
Revenue (ttm)	54.1K
Net income (ttm)	-4.5M
EPS (ttm)	-$5.07
Shares out	1.6M
Volume	11,304
Beta	0.91

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 54.1K
Net income (ttm): -4.5M
EPS (ttm): -$5.07
Market cap: 2.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Conserver

Metric	Value
Amount currency	USD
CIK code	0001514183
Company name	Silo Pharma, Inc.
Country	United States
Country code	US
CUSIP number	82711P300
Earnings date	2026-11-12
Earnings time	amc
Employees	3
Employees change	0
Employees growth	0%
Enterprise value	$-3.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2010
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US82711P3001
Last 10-K release date	2026-03-27
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	2026-06-03
Last stock split type	Reverse
Market cap	$2.1M
Market cap category	Nano-Cap
Next earnings date	2026-11-12
Options	No
Price	$1.30
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	SILO
U.S. state	Florida
Website	https://silopharma.com

Metric

Value

Amount currency

USD

CIK code

0001514183

Company name

Silo Pharma, Inc.

Country

United States

Country code

CUSIP number

82711P300

Earnings date

2026-11-12

Earnings time

amc

Employees

Employees change

Employees growth

Enterprise value

$-3.2M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2010

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US82711P3001

Last 10-K release date

2026-03-27

Last earnings date

2026-08-13

Last refreshed

2026-10-28

Last stock split date

2026-06-03

Last stock split type

Reverse

Market cap

$2.1M

Market cap category

Nano-Cap

Next earnings date

2026-11-12

Options

Price

$1.30

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

SILO

U.S. state

Florida

Website

https://silopharma.com

Metric	Value
Earnings yield	-389.75%
FCF / EV yield	105.09%
FCF yield	-163.03%
P/B ratio	0.3x
P/S ratio	37.89x
Price / tangible book value	0.44x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-389.75%

FCF / EV yield

105.09%

FCF yield

-163.03%

P/B ratio

0.3x

P/S ratio

37.89x

Price / tangible book value

0.44x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Gross margin	-14.77%
Operating margin	-8,250.46%
Pretax margin	-8,269.53%
Profit per employee	$-1.5M
Revenue per employee	$18,026
ROA	-44.25%
ROA (5Y)	-30.05%
ROCE	-91.31%
ROE	-91.23%
ROE (5Y)	-31.36%
ROIC	-56.89%
SBC / revenue	2,804.9%

Metric

Value

Gross margin

-14.77%

Operating margin

-8,250.46%

Pretax margin

-8,269.53%

Profit per employee

$-1.5M

Revenue per employee

$18,026

ROA

-44.25%

ROA (5Y)

-30.05%

ROCE

-91.31%

ROE

-91.23%

ROE (5Y)

-31.36%

ROIC

-56.89%

SBC / revenue

2,804.9%

Metric	Value
EPS growth quarters	2
EPS growth years	3
Net income growth quarters	1
Net income growth years	1
Revenue growth	-25%
Revenue growth 10Y	-1.64%
Revenue growth 3Y	-9.14%
Revenue growth 5Y	10.58%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth

-25%

Revenue growth 10Y

-1.64%

Revenue growth 3Y

-9.14%

Revenue growth 5Y

10.58%

Revenue growth years

Metric	Value
Depreciation and amortization	$11,750
EBIT	$-4.5M
EBITDA	$-4.4M
EPS	$-5.07
FCF per share	$-2.10
Financing cash flow	$2.7M
Free cash flow	$-3.3M
Free cash flow minus SBC	$-4.9M
Gross profit	$-7,987
Investing cash flow	$-455,586
Net cash flow	$-1.1M
Net income	$-4.5M
Operating cash flow minus SBC	$-4.9M
Operating income	$-4.5M
Revenue	$54,077
Stock-based compensation	$1.5M

Metric

Value

Depreciation and amortization

$11,750

EBIT

$-4.5M

EBITDA

$-4.4M

EPS

$-5.07

FCF per share

$-2.10

Financing cash flow

$2.7M

Free cash flow

$-3.3M

Free cash flow minus SBC

$-4.9M

Gross profit

$-7,987

Investing cash flow

$-455,586

Net cash flow

$-1.1M

Net income

$-4.5M

Operating cash flow minus SBC

$-4.9M

Operating income

$-4.5M

Revenue

$54,077

Stock-based compensation

$1.5M

Metric	Value
Altman Z-Score	-3.34
Book value per share	$4.33
Debt / equity	0
Interest coverage	-112.03
Long-term assets	$238,497
Long-term liabilities	$0
Net cash (debt)	$5.2M
Net cash / market cap	255.13%
Net cash growth	-16.5%
Net debt / equity	-1.07
Piotroski F-Score	1
Shareholders' equity	$4.9M
Tangible book value	$4.7M
Tangible book value per share	$4.14
Total assets	$6M
Total cash	$5.2M
Total debt	$0
Total liabilities	$1.1M
WACC	9.25%

Metric

Value

Altman Z-Score

-3.34

Book value per share

$4.33

Debt / equity

Interest coverage

-112.03

Long-term assets

$238,497

Long-term liabilities

Net cash (debt)

$5.2M

Net cash / market cap

255.13%

Net cash growth

-16.5%

Net debt / equity

-1.07

Piotroski F-Score

Shareholders' equity

$4.9M

Tangible book value

$4.7M

Tangible book value per share

$4.14

Total assets

$6M

Total cash

$5.2M

Total debt

Total liabilities

$1.1M

WACC

9.25%

Metric	Value
Asset turnover	0.01
Current assets	$5.7M
Current liabilities	$1.1M
Current ratio	5.36
Net working capital	$-579,449
Quick ratio	4.9
Working capital	$4.6M
Working capital turnover	0.01

Metric

Value

Asset turnover

0.01

Current assets

$5.7M

Current liabilities

$1.1M

Current ratio

5.36

Net working capital

$-579,449

Quick ratio

4.9

Working capital

$4.6M

Working capital turnover

0.01

Metric	Value
Buyback yield / dilution	-170.5%
Dividend yield	0%
Shareholder yield	-170.5%

Metric

Value

Buyback yield / dilution

-170.5%

Dividend yield

Shareholder yield

-170.5%

Metric	Value
150-day SMA	$4.45
1D price change	0.78%
1M price change	-22.29%
1M total return	-22.29%
1W price change	13.33%
1W total return	13.33%
1Y price change	-84.07%
1Y return CAGR	-84.09%
1Y total return	-84.07%
20-day SMA	$1.31
200-day SMA	$4.61
3M price change	-69.09%
3M total return	-69.09%
3Y price change	-93.23%
3Y return CAGR	-59.24%
3Y total return	-93.23%
50-day SMA	$1.82
50-day SMA vs 200-day SMA	50under200
52-week high	$10.43
52-week high date	2026-04-20
52-week low	$1.10
52-week low date	2026-10-13
5Y price change	-99.07%
5Y return CAGR	-60.8%
5Y total return	-99.07%
6M price change	-79.3%
6M total return	-79.3%
All-time high	$1,875.00
All-time high date	2014-05-15
All-time low	$1.10
All-time low date	2026-10-13
Average true range (ATR)	$0.12
Average volume	93.1K
Beta (1Y)	2.84
Beta (2Y)	0.85
Beta (5Y)	0.91
Change from 52-week high	-87.53%
Change from 52-week low	18.18%
Change from all-time high	-99.93%
Change from all-time low	23.64%
Change from open	0%
Day's gap	0.78%
Dollar volume	$14,695
High price	$1.30
Low price	$1.30
Monthly RSI	33
Open price	$1.30
Premarket change	-1.55%
Premarket close	$1.29
Premarket price	$1.27
Premarket volume	360
Previous close	$1.29
Price vs 150-day SMA	-69.44%
Price vs 20-day SMA	3.66%
Price vs 200-day SMA	-70.49%
Price vs 50-day SMA	-25.27%
Relative volume	0.12
RSI	41.35
Sharpe ratio	-1.17
Sharpe ratio (3Y)	-0.12
Sharpe ratio (5Y)	-0.27
Sortino ratio	-1.73
Sortino ratio (3Y)	-0.16
Sortino ratio (5Y)	-0.39
Volume	11.3K
Weekly RSI	26.66
YTD price change	-73.33%
YTD total return	-73.33%

Metric

Value

150-day SMA

$4.45

1D price change

0.78%

1M price change

-22.29%

1M total return

-22.29%

1W price change

13.33%

1W total return

13.33%

1Y price change

-84.07%

1Y return CAGR

-84.09%

1Y total return

-84.07%

20-day SMA

$1.31

200-day SMA

$4.61

3M price change

-69.09%

3M total return

-69.09%

3Y price change

-93.23%

3Y return CAGR

-59.24%

3Y total return

-93.23%

50-day SMA

$1.82

50-day SMA vs 200-day SMA

50under200

52-week high

$10.43

52-week high date

2026-04-20

52-week low

$1.10

52-week low date

2026-10-13

5Y price change

-99.07%

5Y return CAGR

-60.8%

5Y total return

-99.07%

6M price change

-79.3%

6M total return

-79.3%

All-time high

$1,875.00

All-time high date

2014-05-15

All-time low

$1.10

All-time low date

2026-10-13

Average true range (ATR)

$0.12

Average volume

93.1K

Beta (1Y)

2.84

Beta (2Y)

0.85

Beta (5Y)

0.91

Change from 52-week high

-87.53%

Change from 52-week low

18.18%

Change from all-time high

-99.93%

Change from all-time low

23.64%

Change from open

Day's gap

0.78%

Dollar volume

$14,695

High price

$1.30

Low price

$1.30

Monthly RSI

Open price

$1.30

Premarket change

-1.55%

Premarket close

$1.29

Premarket price

$1.27

Premarket volume

360

Previous close

$1.29

Price vs 150-day SMA

-69.44%

Price vs 20-day SMA

3.66%

Price vs 200-day SMA

-70.49%

Price vs 50-day SMA

-25.27%

Relative volume

0.12

RSI

41.35

Sharpe ratio

-1.17

Sharpe ratio (3Y)

-0.12

Sharpe ratio (5Y)

-0.27

Sortino ratio

-1.73

Sortino ratio (3Y)

-0.16

Sortino ratio (5Y)

-0.39

Volume

11.3K

Weekly RSI

26.66

YTD price change

-73.33%

YTD total return

-73.33%

Metric	Value
Float	1.6M
Float percentage	99.08%
Shares change (QoQ)	20.19%
Shares change (YoY)	170.5%
Shares held by insiders	0.92%
Shares held by institutions	7.71%
Shares outstanding	1.6M
Short % of float	2.22%
Short % of shares	2.2%
Short ratio	0.7 days

Metric

Value

Float

1.6M

Float percentage

99.08%

Shares change (QoQ)

20.19%

Shares change (YoY)

170.5%

Shares held by insiders

0.92%

Shares held by institutions

7.71%

Shares outstanding

1.6M

Short % of float

2.22%

Short % of shares

2.2%

Short ratio

0.7 days

Silo Pharma, Inc. (SILO)

Price

Financial snapshot

Fair-value bridge

Latest news · SILO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SILO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SILO

Frequently asked questions